Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kathryn Kloss

Physician Assistant, Medical Tampa, FL Physician Assistant

NPI 1063715092 CMS profile 11136045

1300 N West Shore Blvd Ste 240, Tampa, FL 33607

Open in the dashboard

General payments

$32,842

714 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathryn Kloss of Tampa, FL is reported in the CMS Open Payments database as having received $32,842 across 714 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,123 179
2024 General $5,643 162
2023 General $12,917 160
2022 General $4,804 102
2021 General $5,355 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathryn Kloss
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Kathryn Kloss were reported at $4,123. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Kathryn Kloss Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $5,355 $156 $41–$563 $132
2022 $4,804 $185 $55–$649 $149
2023 $12,917 $199 $58–$717 $160
2024 $5,643 $206 $62–$740 $164
2025 $4,123 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Otsuka America Pharmaceutical, Inc. $9,878 93 payments
  2. AbbVie, Inc. $8,140 95 payments
  3. Idorsia Pharmaceuticals US Inc $4,060 30 payments
  4. ITI, Inc. $2,205 78 payments
  5. Teva Pharmaceuticals USA, Inc. $765 45 payments
  6. Neurocrine Biosciences, Inc. $737 45 payments
  7. Axsome Therapeutics, Inc. $651 24 payments
  8. Noven Therapeutics, LLC $586 30 payments
  9. Janssen Pharmaceuticals, Inc $566 23 payments
  10. Alkermes, Inc. $556 26 payments
  11. Other $4,698 225 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,069 25 payments
  2. Food and Beverage $14,346 670 payments
  3. Travel and Lodging $363 16 payments
  4. Education $64 3 payments
Products named General payments · program years 2021–2025
  1. REXULTI $9,706 82 payments
  2. VRAYLAR $7,833 82 payments
  3. QUVIVIQ $4,060 30 payments
  4. CAPLYTA Psychiatry $1,440 50 payments
  5. CAPLYTA Psychiatry $765 28 payments
  6. Xelstrym $697 30 payments
  7. INGREZZA $680 41 payments
  8. Azstarys $533 28 payments
  9. LYBALVI $526 23 payments
  10. Austedo XR $488 28 payments
  11. Other $8,998 431 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 28 drugs

Part D claims

1,030

Median for Physician Assistant: 241

Drug cost

$392,746

Median for Physician Assistant: $4,110

Branded share of claims

17.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hetlioz Tasimelteon Brand 15 $335,707
Vraylar Cariprazine Hcl Brand 16 $22,476
Sunosi Solriamfetol Hcl Brand 15 $12,639
Aripiprazole Generic 54 $10,026
Duloxetine Hcl Generic 48 $1,265
Clonazepam Generic 113 $1,155
Alprazolam Generic 118 $1,104
Bupropion Xl Bupropion Hcl Brand 53 $1,035
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 27 $821
Buspirone Hcl Generic 36 $763

The 10 drugs with the highest cost, of 28 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
$2,680 — —
CAPLYTA
$573 — —
Xelstrym
$249 — —
Azstarys
$163 — —
Austedo XR
$158 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

714 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record